Iovance Biotherapeutics Inc (IOVA)
SG&A Expenses
$39.27M
Quarterly · Period ending: · USD
IOVA SG&A Expenses
Latest reported$39.27Mperiod ending
Latest reported$39.27Mperiod ending
IOVA Quarterly SG&A Expenses ($17.41K → $39.27M)
Quarterly SG&A Expenses
High-resolution chart · PNG
IOVA sg&a expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 39,272,000 | |
| 38,949,000 | |
| 36,400,000 | |
| 34,555,000 | |
| 37,567,000 | |
| 43,800,000 | |
| 42,503,000 | |
| 39,553,000 | |
| 34,190,000 | |
| 26,119,000 | |
| 29,903,000 | |
| 26,964,000 | |
| 21,927,000 | |
| 28,122,000 | |
| 26,463,000 | |
| 27,893,000 | |
| 26,328,000 | |
| 23,413,000 | |
| 23,849,000 | |
| 20,887,000 | |
| 19,307,000 | |
| 19,621,000 | |
| 16,083,000 | |
| 15,916,000 | |
| 14,353,000 | |
| 13,858,000 | |
| 10,872,000 | |
| 10,029,000 | |
| 10,867,000 | |
| 9,081,000 | |
| 7,525,000 | |
| 7,113,000 | |
| 6,827,000 | |
| 6,965,000 | |
| 5,375,000 | |
| 4,590,000 | |
| 3,928,000 | |
| 4,259,000 | |
| 5,085,000 | |
| 10,498,000 | |
| 7,264,000 | |
| 2,818,000 | |
| 3,927,000 | |
| 2,660,000 | |
| 2,385,000 | |
| 2,900,000 | |
| 3,181,000 | |
| 2,449,000 | |
| 1,749,000 | |
| 1,957,000 | |
| 981,913 | |
| 2,459,000 | |
| 779,260 | |
| 434,913 | |
| 1,473,000 | |
| 1,378,000 | |
| 1,376,000 | |
| 2,250,000 | |
| 2,269,000 | |
| 5,814,000 | |
| 10,561,000 | |
| 658,250 | |
| 496,077 | |
| 167,027 | |
| 84,629 | |
| 67,680 | |
| 2,012 | |
| 3,137 | |
| 3,012 | |
| 6,279 | |
| -16,245 | |
| 2,138 | |
| 3,702 | |
| 17,413 |